Client of a consultant lobbyist
Innovative Medicines Canada
- Meetings this Parliament
- 0
- With MPs
- 0
- Since Nov 2021
- 5
- Active registrations
- 0
Most recent reported meeting: Mar 21, 2023.
Lobbying by Innovative Medicines Canada: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingRegistrations in effect
Innovative Medicines Canada has no active registration. Organizations must register once paid lobbying passes the legal threshold, and their registration ends when it stops.
Reported meetings
Spreadsheet-
Reported by Andy Singh · Consultant
- Adam Chambers · Member of Parliament
- Philip Lawrence · Member of Parliament
- Francesco Sorbara · Member of Parliment, House of Commons
Research and DevelopmentTaxation and Finance
-
Reported by Andy Singh · Consultant
- chris zhou · Policy Advisor, Global Affairs Canada (GAC)
Intellectual PropertyInternational Trade
-
Reported by Andy Singh · Consultant
- Sandenga Yeba · Senior Policy Advisor, Health Canada (HC)
Health
-
Reported by Andy Singh · Consultant
- Sandenga Yeba · Senior Policy Advisor, Health Canada (HC)
Health
-
Reported by Andy Singh · Consultant
- Jean-Sebastien Bock · Director of Policy, Health Canada (HC)
- Sandenga Yeba · Senior Policy Advisor, Health Canada (HC)
Health
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.